Drugs / SBR759A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01069692 | Feb → Oct 2010 | chronic kidney disease, hyperphosphatemia | Novartis | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SBR759A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01069692 ↗ |